If taken with food, the peak may come around 4.5 to 5 hours post-dose
It still far too early to know whether or not GLP-1 receptor agonists could improve stroke outcomes in nondiabetic patients
In hypertension, GLP-1 attenuates the excitability of carotid body cells diminishing sympathetic activation, augments renal blood flow to promote natriuresis and diuresis as well as facilitates generation of nitric oxide in vascular smooth muscle cells
However, due to modern lifestyle challenges, natural production alone may not always be enough
Phase 2 trials demonstrated A1C reductions of up to 2.02% in participants with type 2 diabetes, bringing average levels from 8.1% down to 6.08%
Notably, we found no change in Glud1 mRNA counts in C- Glud1 +/ mice